We are one of only a few hospitals in the country offering a relatively new treatment option, called UroLift®, for men with benign prostatic hyperplasia (BPH).
The UroLift® system received NICE guidance approval in 2014, as a proven surgical option for the treatment of lower urinary tract symptoms due to an enlarged prostate due to BPH. The treatment works by using a number of tiny implants to lift and hold the enlarged prostate tissue out of the way so that it no longer blocks the urethra, resulting in improved urine flow.
UroLift® is unique in that it does not destroy the prostate tissue, meaning that it does not cause erectile dysfunction or permanent urinary incontinence. It is a minimally invasive procedure which can means patients can return home and to normal daily activities soon after treatment.
For men older than 50 years, benign prostatic hyperplasia (BPH) is a common prostate problem. UroLift® is an alternative for patients looking for something other than drug therapy or more invasive surgery. Treatment might be right for you if any of the following apply to you:
Typically you will be able to go home after the procedure without a catheter. You should experience rapid symptom relief without complications, as early as two weeks after the procedure. Results are long-lasting, with no medications required to sustain relief.
Surgery to remove a benign scrotal lump.
Surgery to remove part of the prostate gland.
A urethrotomy is an operation to treat a narrowing of the urethra (tube that carries urine from the bladder to the penis).